DUBLIN, May 25, 2023 /PRNewswire/ — The “Technology Innovations and Growth Opportunities in Inhaled Therapeutics” report has been added to ResearchAndMarkets.com’s offering.
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalable biologics for conditions where injection delivery is the norm.
This study highlights important formulations for inhalable biologics and examines the factors that drive or limit market growth. The research examines the pipeline of monoclonal antibodies and vaccines in development and evaluates R&D trends, partnership and collaboration trends, funding and investment analysis, patent analysis, and the outlook for inhalable biologics. The study identifies significant growth opportunities for industry players in the field.
Questions this study answers:
- What factors drive or limit the industry’s growth?
- What are the innovative methods for formulating inhalable biologics?
- What does the pipeline analysis for inhalable vaccines and monoclonal antibodies look like?
- What are the R&D trends and projected developments of the technologies?
- What are the funding evaluations, patent evaluations, regulatory environments, and trends for partnerships and collaborations for inhalable biologics?
- What are the growth opportunities for technology developers in the inhalable biologics space?
Key Topics Covered:
1. Strategic Imperatives
- Why Is It Increasingly Difficult to Grow? The Strategic Imperative 8: Factors Creating Pressure on Growth
- The Strategic Imperative 8
- The Impact of the Top 3 Strategic Imperatives on the Inhaled Therapeutics Industry
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
2. Growth Opportunity Analysis
- Scope of Analysis
- The Need for Inhalation Biologics Formulation
- Inhalation Drug Delivery – Introduction
- Segmentation – Formulations for Drug Inhalation
- Pros and Cons of Formulation and Drug Delivery Systems for Inhalation
- Examples of Novel Formulations and Drug Delivery System for Inhalable Biologics
- Promising Inhalation Therapy – Advantages of Inhalational Monoclonal Antibodies (mAbs) and Vaccines
- Growth Drivers
- Growth Restraints
3. Industry Assessment and Analysis
- Pipeline Analysis of Inhaled Vaccines and mAbs
- Vaccines and mAbs under Clinical Development
- Primary Technologies – AttenuBlock Platform Technology (Codon Deoptimization for Live Attenuated Vaccine Candidates)
- Primary Technologies – Nanoemulsion Platform (Intranasal Adjuvant Technology)
4. Innovation Ecosystem
- R&D Trends
- Collaboration and Partnership Trends
- Funding and Investment Analysis
- Patent Analysis
- Future Roadmap
5. Growth Opportunity Universe
- Growth Opportunity 1: Drug Repurposing Using Nanotechnology to Produce a Nebulizer Solution
- Growth Opportunity 2: Partnering with a CDMO that Offers End-to-end Services
- Growth Opportunity 3: Gene-based Antibody Delivery for Safe Inhaled Administration
6. Next Steps
For more information about this report visit https://www.researchandmarkets.com/r/7ki2s4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
